Phosphorylation of TET2 by AMPK is indispensable in myogenic differentiation

被引:34
|
作者
Zhang, Ting [1 ,2 ]
Guan, Xiaowen [1 ,2 ]
Choi, Un Lam [1 ,2 ]
Dong, Qiang [3 ]
Lam, Melody M. T. [1 ,2 ]
Zeng, Jianming [1 ,2 ]
Xiong, Jun [3 ]
Wang, Xianju [1 ,2 ]
Poon, Terence C. W. [1 ,2 ]
Zhang, Hongjie [1 ,2 ]
Zhang, Xuanjun [1 ,2 ]
Wang, Hailin [5 ]
Xie, Ruiyu [1 ,2 ]
Zhu, Bing [3 ,4 ]
Li, Gang [1 ,2 ]
机构
[1] Univ Macau, Fac Hlth Sci, Ave Univ, Taipa, Macau, Peoples R China
[2] Univ Macau, Fac Hlth Sci, Canc Ctr, Taipa, Macau, Peoples R China
[3] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China
[4] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China
[5] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China
关键词
AMPK; TET2; Phosphorylation; Myogenesis; PAX7; CHROMATIN ACCESSIBILITY; TRANSCRIPTION FACTORS; DNA METHYLATION; SKELETAL-MUSCLE; CHIP-SEQ; PROTEINS; PAX7; 5-METHYLCYTOSINE; SPECIFICATION; EXPRESSION;
D O I
10.1186/s13072-019-0281-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BackgroundTET-mediated oxidation of 5-mC participates in both passive and active DNA demethylation, which exerts a significant influence on diverse biological processes. Mass spectrometry has identified multiple phosphorylation sites of TET2. However, the functions of these phosphosites and their corresponding kinases are mostly unknown.ResultsHere, we showed that AMP-activated protein kinase (AMPK) phosphorylates murine TET2 at the serine residue 97 (S97), andthe phosphorylation enhances TET2 stability through promoting its binding to 14-3-3. AMPK ablation resulted in decreased global 5-hmC levels at the myotube stages, severe differentiation defects of C2C12 cells and significantly, total loss of expression of Pax7. Genome-wide analyses revealed increased DNA methylation at genic and enhancer regions of AMPK-null myoblasts and myotubes. Using CRISPR/Cas9 technology, we showed that a novel enhancer, which is hypermethylated in AMPK-null cells, regulates Pax7 expression. The phospho-mimicking mutant, TET2-S97E, could partly rescue the differentiation defect in AMPK-ablated C2C12 cells.ConclusionsTogether, our data demonstrated that AMPK is a critical regulator of myogenesis, partly through phosphorylating TET2.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Dysregulation of TET2 in hematologic malignancies
    Shigeru Chiba
    International Journal of Hematology, 2017, 105 : 17 - 22
  • [42] TET2, an “ambiguous” player in inflammation
    Ana María Espinosa-Oliva
    Miguel Angel Burguillos
    Neural Regeneration Research, 2020, 15 (08) : 1481 - 1482
  • [43] TET2 mutations in childhood leukemia
    Langemeijer, S. M. C.
    Jansen, J. H.
    Hooijer, J.
    van Hoogen, P.
    Stevens-Linders, E.
    Massop, M.
    Waanders, E.
    van Reijmersdal, S. V.
    Stevens-Kroef, M. J. P. L.
    Zwaan, C. M.
    van den Heuvel-Eibrink, M. M.
    Sonneveld, E.
    Hoogerbrugge, P. M.
    van Kessel, A. Geurts
    Kuiper, R. P.
    LEUKEMIA, 2011, 25 (01) : 189 - 192
  • [44] The Potential Equivalents of TET2 Mutations
    Pasca, Sergiu
    Jurj, Ancuta
    Zdrenghea, Mihnea
    Tomuleasa, Ciprian
    CANCERS, 2021, 13 (07)
  • [45] TET2: the fat controller of leptin
    Callen C.Goldsmith
    Garron T.Dodd
    Life Metabolism, 2024, 3 (04) : 14 - 16
  • [46] Mutation in TET2 in Myeloid Cancers
    Delhommeau, Francois
    Dupont, Sabrina
    Della Valle, Veronique
    James, Chloe
    Trannoy, Severine
    Masse, Aline
    Kosmider, Olivier
    Le Couedic, Jean-Pierre
    Robert, Fabienne
    Alberdi, Antonio
    Lecluse, Yann
    Plo, Isabelle
    Dreyfus, Francois J.
    Marzac, Christophe
    Casadevall, Nicole
    Lacombe, Catherine
    Romana, Serge P.
    Dessen, Philippe
    Soulier, Jean
    Viguie, Franck
    Fontenay, Michaela
    Vainchenker, William
    Bernard, Olivier A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22): : 2289 - 2301
  • [47] TET2 mutations in childhood leukemia
    S M C Langemeijer
    J H Jansen
    J Hooijer
    P van Hoogen
    E Stevens-Linders
    M Massop
    E Waanders
    S V van Reijmersdal
    M J P L Stevens-Kroef
    C M Zwaan
    M M van den Heuvel-Eibrink
    E Sonneveld
    P M Hoogerbrugge
    A Geurts van Kessel
    R P Kuiper
    Leukemia, 2011, 25 : 189 - 192
  • [48] The Role of TET2 in Hematologic Neoplasms
    Holmfeldt, Linda
    Mullighan, Charles G.
    CANCER CELL, 2011, 20 (01) : 1 - 2
  • [49] TET2: the fat controller of leptin
    Goldsmith, Callen C.
    Dodd, Garron T.
    LIFE METABOLISM, 2024, 3 (04):
  • [50] TET2: epigenetic safeguard for HSC
    Ko, Myunggon
    Rao, Anjana
    BLOOD, 2011, 118 (17) : 4501 - 4503